Attached files
| file | filename |
|---|---|
| EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Monopar Therapeutics | exhibit31-2.htm |
| EX-10 - MATERIAL CONTRACTS - Monopar Therapeutics | prxconsulting2020agreemen.htm |
| EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Monopar Therapeutics | exhibit31-1.htm |
| EX-23 - CONSENTS OF EXPERTS AND COUNSEL - Monopar Therapeutics | exhibit23-1.htm |
| EX-21 - SUBSIDIARIES OF THE REGISTRANT - Monopar Therapeutics | exhibit21-1.htm |
| EX-4 - INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES INSTRU - Monopar Therapeutics | exhibit4-1.htm |
| 10-K - PRIMARY DOCUMENT - Monopar Therapeutics | a10-k12312020.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report on Form 10-K of Monopar
Therapeutics Inc. (the Company) for the year ended December 31,
2020, as filed with the Securities and Exchange Commission on the
date hereof (the Report), we, Chandler D. Robinson, and Kim R.
Tsuchimoto, hereby certify, pursuant to 18 U.S.C. §1350, as
adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002,
that:
(1)
the Report fully
complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2)
the information
contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Company.
/s/ Chandler D. Robinson
Chandler
D. Robinson
Chief
Executive Officer
March
25, 2021
/s/ Kim R. Tsuchimoto
Kim R.
Tsuchimoto
Chief
Financial Officer
March
25, 2021
This
certification accompanies the Form 10-K to which it relates, is not
deemed filed with the Securities and Exchange Commission and is not
to be incorporated by reference into any filing of Monopar
Therapeutics Inc. under the Securities Act of 1933, as amended, or
the Securities Exchange Act of 1934, as amended (whether made
before or after the date of the Form 10-K), irrespective of any
general incorporation language contained in such
filing.